Thrombotic thrombocytopenic purpura (TTP) is a rare
but acute, life-threatening condition which may be precipitated by pregnancy.
This disorder that presents with thrombocytopenia, haemolytic anemia, and
clinical consequences of microvascular thrombosis such as stroke. The exact
cause is not known but it is associated with a deficiency of ADAMTS13 enzymes.Immune mediated TTP is more common and can present in pregnancy. The aim of
this case is to bring awareness as many clinicians are unaware of this
condition in pregnancy, its diagnosis may be missed or delayed, leading to
fetal loss or serious maternal implications. In this case the patient presented
at 29 weeks with stroke in Emergency department, referred to delivery suit for
Obstetric review, with suspicion of Pre-eclampsia/HELLP. The diagnosis of TTP
was achieved by a multidisciplinary team who worked tirelessly together. The
patient was transferred to a Specialist Tertiary Care Centre for further
management. The pregnancy continued until 33 weeks and 5 days. She underwent an
emergency caesarean section for fetal distress. Steroids and Rituximab were
continued postnatally. The outcome was favourable due to fast and efficient
multidisciplinary care. Awareness of this rare but important condition can lead
to recognition of clinical presentation, prompt diagnosis and appropriate
management.
References
[1]
Plautz, W., Revalidation, J., Dyer, M. and Rollins-Raval, M. (2018) ADAMTS13: Origin, Application, and Prospects. Transfusion, 58, 2453-2462.
https://doi.org/10.1111/trf.14804
[2]
Scully, M., Cataland, S. and Coppo, P. (2017) Consensus on the Standardisation of Terminology in Thrombotic Thrombocytopenic Purpura and Related Thrombotic Microangiopathies. Journal of Thrombosis and Haemostasis, 15, 312-322.
https://doi.org/10.1111/jth.13571
[3]
Zhou, L., Zhu, Y., Jiang, M., et al. (2021) Pregnancy Associated Thrombotic Thrombocytopenic Purpura Complicated by Sjögren’s Syndrome and Non-Neutralising Antibodies to ADAMTS13: A Case Report. BMC Pregnancy and Childbirth, 21, Article No. 804. https://doi.org/10.1186/s12884-021-04167-9
[4]
Vesely, S.K., George, J.N., Lammle, B., et al. (2003) ADAMTS13 Activity in Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome: Relation to Presenting Features and Clinical Outcomes in a Prospective Cohort of 142 Patients. Blood, 102, 60-68. https://doi.org/10.1182/blood-2003-01-0193
[5]
Baz, E.M.K., Mahfouz, R.A., Masri, A.F., et al. (2001) Thrombotic Thrombocytopenic Purpura in a Case of Scleroderma Renal Crisis Treated with Twice-Daily Therapeutic Plasma Exchange. Renal Failure, 23, 737-742.
https://doi.org/10.1081/JDI-100107372
[6]
Scully, M., Thomas, M., Underwood, M., et al. (2014) Thrombotic Thrombocytopenic Purpura and Pregnancy: Presentation, Management, and Subsequent Pregnancy Outcome. Blood, 124, 211-219.
https://doi.org/10.1182/blood-2014-02-553131
[7]
Sayani, F.A. and Abrams, C.S. (2015) How I Treat Refractory Thrombotic Thrombocytopenic Purpura. Blood, 125, 3860-3867.
https://doi.org/10.1182/blood-2014-11-551580
[8]
Yue, C., Su, J., Gao, R., Wen, Y., Li, C., Chen, G., et al. (2018) Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus-Associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles. The Journal of Rheumatology, 45, 1549-1556. https://doi.org/10.3899/jrheum.170811
[9]
Sánchez-Luceros, A., Farías, C.E., Amaral, M.M., Kempfer, A.C., Votta, R., Marchese, C., et al. (2004) von Willebrand Factor-Cleaving Protease (ADAMTS13) Activity in Normal Non-Pregnant Women, Pregnant and Post-Delivery Women. Thrombosis and Haemostasis, 92, 1320-1326. https://doi.org/10.1160/TH03-11-0683
[10]
Jamme, M. and Rondeau, E. (2017) The PLASMIC Score for Thrombotic Thrombocytopenic Purpura. The Lancet Haematology, 4, E148-E149.
https://doi.org/10.1016/S2352-3026(17)30024-8
[11]
Schreiber, K. and Hunt, B.J. (2019) Managing Antiphospholipid Syndrome in Pregnancy. Thrombosis Research, 181, S41-S46.
https://doi.org/10.1016/S0049-3848(19)30366-4
[12]
Tang, N., Wang, X., Li, D. and Sun, Z. (2018) Validation of the PLASMIC Score, a Clinical Prediction Tool for Thrombotic Thrombocytopenic Purpura Diagnosis, in Chinese Patients. Thrombosis Research, 172, 9-13.
https://doi.org/10.1016/j.thromres.2018.10.010